


Searching News Database: microparticle
HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
HSMN NewsFeed - 20 May 2016
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 22 Aug 2012
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
HSMN NewsFeed - 20 Sep 2011
SurModics IVD Introduces A New BioFX(R) TMB Enhanced HRP Membrane Substrate
SurModics IVD Introduces A New BioFX(R) TMB Enhanced HRP Membrane Substrate
HSMN NewsFeed - 15 Oct 2010
SurModics Announces Organizational Changes to Reduce Cost Structure and Renew Focus on Business Units
SurModics Announces Organizational Changes to Reduce Cost Structure and Renew Focus on Business Units
HSMN NewsFeed - 21 Jun 2010
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
HSMN NewsFeed - 27 Jan 2009
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
HSMN NewsFeed - 30 Oct 2008
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
HSMN NewsFeed - 17 Sep 2008
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
HSMN NewsFeed - 18 Aug 2008
Oncologix Announces Signing of Asset Purchase Agreement Pertaining to Selling Its Oncosphere Assets
Oncologix Announces Signing of Asset Purchase Agreement Pertaining to Selling Its Oncosphere Assets
HSMN NewsFeed - 31 Mar 2008
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
HSMN NewsFeed - 31 Oct 2007
SurModics and OakRiver Technology Collaborate on Advanced Coating Equipment
SurModics and OakRiver Technology Collaborate on Advanced Coating Equipment
HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
HSMN NewsFeed - 20 Sep 2006
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Additional items found! 30
Members Archive contains
30 additional stories matching:
microparticle
(Password required)
microparticle
(Password required)
